Find Reports

Select Report Type

Learn More about Reports

Reimbursement Review

Displaying 1251 - 1258 of 1258

Health Technology Review

Filter

Project Sub Line

Last Updated

Min

Max

Items per page

Export to CSV

Displaying 576 - 589 of 589

Horizon Scan

Filter

Project Sub Line

Last Updated

Min

Max

Items per page

Export to CSV

Displaying 101 - 111 of 111

Projects in Progress

Filter

Project Sub Line

Last Updated

Min

Max

Items per page

Export to CSV

Displaying 26 - 40 of 40

View All Reports

Filter

Project Sub Line

Last Updated

Min

Max

Items per page

Export to CSV

Displaying 1451 - 1475 of 2093

Please scroll or swipe to the right to view the full content.

Title	Files	Last Updated Sort ascending	Project Line	Project Sub Line	Status	Project Number
lumacaftor/ivacaftor	SR0559 Orkambi - CDEC Final Recommendation October 4, 2018.pdf SR0559_Orkambi_CL_Report.pdf SR0559_Orkambi_PE_Report.pdf SR0559_Orkambi_PI_Submissions.pdf	Nov 19, 2018	Reimbursement Review		Complete	SR0559-000
filgrastim		Nov 19, 2018	Reimbursement Review		Cancelled	SE0596-000
Engaging with History Taking for Adverse Childhood Experiences in Care: A Rapid Qualitative Review	Engaging with History Taking for Adverse Childhood Experiences in Care: A Rapid…	Nov 19, 2018	Health Technology Review	Rapid Review	Completed	RC1045-000
Opdivo in combo with Yervoy for Renal Cell Carcinoma – Details	pcodr_profund_10132opdivo-yervoy_rcc.pdf pcodr_opdivo_yervoy_rcc_fn_rec.pdf pcodr_opdivo_yervoy_rcc_fn_cgr.pdf pcodr_opdivo_yervoy_rcc_fn_egr.pdf pcodr_opdivo_yervoy_rcc_in_rec.pdf pcodr_opdivo_yervoy_rcc_pagfdk.pdf pcodr_opdivo_yervoy_rcc_fdk_bms.pdf pcodr_opdivo_yervoy_rcc_clnfdk.pdf pcodr_opdivo_yervoy_rcc_coi_pt.pdf pcodr_opdivo_yervoy_rcc_coi_cln.pdf	Nov 16, 2018	Reimbursement Review		Complete	PC0132-000
Gazyva for Follicular Lymphoma (previously untreated) – Details	pcodr_provfund_10126obinutuzumab_gazyva_fl_preun.pdf pcodr_obinutuzumab_gazyva_fl_preun_fn_rec.pdf pcodr_obinutuzumab_gazyva_fl_preun_fn_cgr.pdf pcodr_obinutuzumab_gazyva_fl_preun_fn_egr.pdf pcodr_obinutuzumab_gazyva_fl_preun_in_rec.pdf pcodr_obinutuzumab_gazyva_fl_preun_pagfdk.pdf pcodr_obinutuzumab_gazyva_fl_preun_fdk_hlr.pdf pcodr_obinutuzumab_gazyva_fl_preun_clnfdk.pdf pcodr_obinutuzumab_gazyva_fl_preun_coi_pt.pdf pcodr_obinutuzumab_gazyva_fl_preun_coi_cln.pdf	Nov 16, 2018	Reimbursement Review		Complete	PC0126-000
Erleada for Castrate Resistant Prostate Cancer - Details	pcodr_provfund_apalutamide_erleada_nm-cprc.pdf pcodr_apalutamide_erleada_crpc_fn_rec.pdf pcodr_apalutamide_erleada_crpc_fn_cgr.pdf pcodr_apalutamide_erleada_crpc_fn_egr.pdf pcodr_apalutamide_erleada_crpc_in_rec.pdf pcodr_apalutamide_erleada_crpc_pagfdk.pdf pcodr_apalutamide_erleada_crpc_fdk_janssen.pdf pcodr_apalutamide_erleada_crpc_ptfdk.pdf pcodr_apalutamide_erleada_crpc_clnfdk.pdf pcodr_apalutamide_erleada_crpc_coi_pt.pdf pcodr_apalutamide_erleada_crpc_coi_cln.pdf	Nov 16, 2018	Reimbursement Review		Complete	PC0133-000
Beleodaq for Peripheral T-Cell Lymphoma – Detail		Oct 24, 2018	Reimbursement Review		Withdrawn	PC0139-000
Dapagliflozin	cdr_SR0445_Forxiga.pdf SR0445_complete_Forxiga-May_2_16-e.pdf SR0445_Forxiga_CL_Report.pdf SR0445_Forxiga_PE_Report.pdf	Oct 23, 2018	Reimbursement Review		Complete	SR0445-000
Riociguat	cdr_SR0438_Adempas-PAH.pdf SR0438_complete_Adempas-Dec-21-15_e.pdf SR0438_Adempas_CL_Report.pdf SR0438_Adempas_PE_Report.pdf SR0438_Adempas_PI_Submissions.pdf	Oct 23, 2018	Reimbursement Review		Complete	SR0438-000
Blincyto for MRD-positive B-cell precursor ALL		Oct 16, 2018	Reimbursement Review		Withdrawn	PC0143-000
CADTH Pharmaceutical Reviews Update — Issue 3		Oct 11, 2018	Reimbursement Review	Pharmaceutical Review Update
ticagrelor	cdr_SR0474_Brilinta.pdf SR0474_complete_Brilinta-Aug-29-16.pdf SR0474_Brilinta_CL_Report.pdf SR0474_Brilinta_PE_Report.pdf SR0474_Brilinta_PI_Submissions.pdf	Oct 10, 2018	Reimbursement Review		Complete	SR0474-000
Canagliflozin and metformin hydrochloride	cdr_SR0480_TBC.pdf SR0480_complete_Invokamet-Aug-29-16.pdf SR0480_Invokamet_Combination_Product_Subsmission_Report.pdf SR0480_Invokamet_PI_Submissions.pdf	Oct 10, 2018	Reimbursement Review		Complete	SR0480-000
Tesamorelin	cdr_SR0477_Egrifta.pdf SR0477_complete_Egrifta_Aug-26-16.pdf SR0477_Egrifta_CL_Report.pdf SR0477_Egrifta_PE_Report.pdf SR0477_Egrifta_PI_Submissions.pdf	Oct 10, 2018	Reimbursement Review		Complete	SR0477-000
Emtricitabine /tenofovir alafenamide	cdr_SR0470_TBC.pdf SR0470_complete_Descovy-Aug-26-16.pdf SR0470_Descovy_CL_Report.pdf SR0470_Descovy_PE_Report.pdf SR0470_Descovy_PI_Submissions.pdf	Oct 9, 2018	Reimbursement Review		Complete	SR0470-000
Adalimumab	cdr_SR0450_Humira.pdf SR0450_complete_Humira-Apr-19-16_e.pdf SR0450_Humira_UC_CL_Report.pdf SR0450_Humira_UC_PE_Report.pdf SR0450_Humira_UC_PI_Submissions.pdf	Oct 9, 2018	Reimbursement Review		Complete	SR0450-000
Tiotropium / olodaterol	cdr_SR0436_Inspiolto_Respimat.pdf SR0436_complete_Inspiolto-Respimat-Dec_21-15-e.pdf SR0436_Inspiolto_Respimat_CL_Report.pdf SR0436_Inspiolto_Respimat_PE_Report.pdf SR0436_Inspiolto_Respimat_PI_Submissions.pdf	Oct 9, 2018	Reimbursement Review		Complete	SR0436-000
An Overview of Clinical Applications of Artificial Intelligence		Oct 1, 2018	Horizon Scan	Emerging Health Technologies	Completed	EH0070-000
fluticasone furoate/umeclidinium/vilanterol	SR0562_cdr_complete_Trelegy_Ellipta_Aug_27_18.pdf SR0562_TrelegyEllipta_CL_Report.pdf SR0562_TrelegyEllipta_PE_Report.pdf SR0562_TrelegyEllipta_PI_Submissions.pdf	Sep 19, 2018	Reimbursement Review		Complete	SR0562-000
eluxadoline	SR0560_cdr_complete_Viberzi_Aug_29_18.pdf SR0560_Viberzi_CL_Report.pdf SR0560_Viberzi_PE_Report.pdf SR0560_Viberzi_PI_Submissions.pdf	Sep 18, 2018	Reimbursement Review		Complete	SR0560-000
CADTH Pharmaceutical Reviews Update — Issue 2		Sep 13, 2018	Reimbursement Review	Pharmaceutical Review Update
Perampanel	SR0458 Fycompa PGTCS .pdf SR0458_complete_Fycompa_May-20-16_e.pdf SR0458_Fycompa_PGTCS_CL_Report.pdf SR0458_Fycompa_PE.pdf SR0458_Fycompa_PI_Submissions_Consolidated_validated.pdf	Sep 13, 2018	Reimbursement Review		Complete	SR0458-000
Adalimumab	SR0455 Humira HS.pdf SR0455_complete_Humira-HS_May-24-16_e.pdf SR0455_HumiraHS_CL_Report.pdf SR0455_HumiraHS_PE_Report.pdf SR0455 Humira HS - _PI_Submissions_Consolidated_validated.pdf	Sep 13, 2018	Reimbursement Review		Complete	SR0455-000
Certolizumab pegol	SR0394 Cimzia PsA.PDF cdr_complete_SR0394_Cimzia-PsA_Apr-21-15.pdf SR0394_CimziaPsA_CL_Report.pdf SR0394_CimziaPsA_PE_Report.pdf SR0394 Cimzia PsA_PI_Submissions.pdf	Sep 7, 2018	Reimbursement Review		Complete	SR0394-000
Denosumab (Drug Plan Submission)	SR0433-000 Xgeva.pdf SR0433-000_complete_Xgeva_BC-Mar_1_16_e.pdf SR0433_000_XgevaBC_CL_Report.pdf SR0433_000_XgevaBC_PE_Report.pdf	Sep 7, 2018	Reimbursement Review		Complete	SR0433-000